World journal of urologyHumansMaleAntibodiesBispecificProstatic Neoplasms
Bispecific antibodies in metastatic castration-resistant prostate cancer: therapeutic strategies and frontier advances.
Jia Wei He, Pei Zhen Li, Zi Xuan Huang
Published: 202510.1007/s00345-025-06075-5
Abstract
PURPOSE: To summarize the therapeutic strategies, efficacy, safety, and advances of bispecific antibodies (BsAbs) in metastatic castration-resistant prostate cancer (mCRPC), and analyze their current challenges and future directions. METHODS: A compr…
Preview only. Read the full abstract at the source